4.6 Article

Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial

Journal

BMC CANCER
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1471-2407-14-239

Keywords

Manual lymphatic drainage; Complete Decongestive Therapy; Breast cancer

Categories

Funding

  1. Centre for Clinical Research, Hospital of Southwest Jutland, Denmark
  2. Oak Foundation
  3. Region of Southern Denmark
  4. Research Fundation

Ask authors/readers for more resources

Background: Physical therapy treatment of patients with lymphedema includes treatment based on the principles of 'Complete Decongestive Therapy' (CDT). CDT consists of the following components; skin care, manual lymphatic drainage, bandaging and exercises. The scientific evidence regarding what type of treatment is most effective is sparse. The objective of this study is to investigate whether CDT is equally effective if it includes manual lymphatic drainage or not in the treatment of arm lymphedema among patients with breast cancer. Methods/Design: A randomized, single-blind, equivalence trial. A total of 160 breast cancer patients with arm lymphedema will be recruited from 3 hospitals and randomized into one of two treatment groups A: Complete Decongestive Therapy including manual drainage or B: Complete Decongestive Therapy without manual lymphatic drainage. The intervention period will be approximately 4 weeks followed by a 6 month follow-up period (7 months from baseline). Primary outcome variable: the percentage volume reduction of lymphedema (%) from baseline to 7 months. Secondary outcome variables: Differences from baseline to week 4 and from week 4 to month 7 in circumference of the arm (cm), body weight (kg), patient sensation of heaviness (scale range: 0-10), patient sensation of tension (scale range: 0-10), and quality of life (EQ 5D 5 L questionnaire). All measurements are standardized and will be performed before randomization, after 4 weeks and after 7 months. Discussion: This randomized controlled study seeks to provide data on an effective treatment for patients with breast cancer related arm lymphedema and which at the same time causes minimal patient inconvenience.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Response to: 'Correspondence on 'Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial'' by McGonagle et al

Maja Skov Kragsnaes, Jens Kjeldsen, Hans Christian Horn, Heidi Lausten Munk, Jens Kristian Pedersen, Soren Andreas Just, Palle Ahlquist, Jesper Romhild Davidsen, Anna Christine Nilsson, Richard Rottger, Mogens Kruhoffer, Julian R. Marchesi, Karsten Kristiansen, Robin Christensen, Torkell Ellingsen

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Rheumatology

Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized Trials

Morten B. Pedersen, Peter Thinggaard, Rinie Geenen, Marianne U. Rasmussen, Maarten De Wit, Lyn March, Philip Mease, Ernest Choy, Philip G. Conaghan, Lee Simon, Anne Faber Hansen, Simon Tarp, Berit Schiottz-Christensen, Carsten B. Juhl, Sabrina M. Nielsen, Kirstine Amris, Robin Christensen

Summary: Biopsychosocial rehabilitation has a significant but clinically small beneficial effect on pain relief among patients with inflammatory arthritis and osteoarthritis (OA), with no difference in harm.

ARTHRITIS CARE & RESEARCH (2023)

Review Rheumatology

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation

Maarten H. P. Butink, Casper Webers, Suzanne M. M. Verstappen, Louise Falzon, Neil Betteridge, Dieter Wiek, Anthony D. Woolf, Tanja A. Stamm, Gerd R. Burmester, Johannes W. J. Bijlsma, Robin Christensen, Annelies Boonen

Summary: A systematic review found that non-pharmacological interventions have small effects on work participation in people with rheumatic and musculoskeletal diseases. The effectiveness of these interventions depends on contextual factors such as disease, population risk status, intervention characteristics, and outcome of interest.

RMD OPEN (2023)

Article Dermatology

Attempted treatment of primary axillary hyperhidrosis with one session of either Neodymium YAG laser or Intense Pulsed Light: A within patient randomized trial of treated versus untreated contralateral axilla

Elisabeth H. Taudorf, Mattias Henning, Jonas Olsen, Linnea Thorlacius, Robin Christensen, Gregor Jemec

Summary: This study aimed to compare the efficacy of Nd:YAG laser and IPL in treating PAH. The results showed no significant difference in sweat secretion between the treated group and the control group, and both treatments were well tolerated with minimal side effects.

LASERS IN SURGERY AND MEDICINE (2023)

Review Rheumatology

Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis

Andriko Palmowski, Sabrina M. Nielsen, Zhivana Boyadzhieva, Abelina Schneider, Anne Pankow, Linda Hartman, Jose A. P. Da Silva, John Kirwan, Siegfried Wassenberg, Christian Dejaco, Robin Christensen, Maarten Boers, Frank Buttgereit

Summary: The study aimed to assess the safety and efficacy of long-term low-dose glucocorticoids in Rheumatoid Arthritis (RA). The analysis found that low-dose glucocorticoids did not increase the risk of adverse events, except for a higher risk of infections. It also showed moderate to high evidence of improvement in disease activity and function in RA.

RHEUMATOLOGY (2023)

Article Rheumatology

Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study

Z. R. Stisen, S. M. Nielsen, S. B. Ditlev, M. Skougaard, A. Egeberg, M. Mogensen, T. S. Jorgensen, L. Dreyer, R. Christensen, L. E. Kristensen

Summary: The study aimed to assess the changes and trajectories in serum NGAL during 12 months of anti-inflammatory treatment in PsA patients. The results showed that serum NGAL did not show significant changes or correlations with PsA outcomes, indicating that it is not a suitable biomarker for disease activity and monitoring.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Review Rheumatology

Effectiveness of patient education as a stand-alone intervention for patients with chronic widespread pain and fibromyalgia: a systematic review and meta-analysis of randomized trials

P. H. Duhn, E. E. Waehrens, M. B. Pedersen, S. M. Nielsen, H. Locht, H. Bliddal, R. Christensen, K. Amris

Summary: This systematic review evaluates the benefits and potential harms of patient education as a stand-alone intervention for individuals with chronic widespread pain and fibromyalgia. The results show that patient education as a stand-alone intervention can improve patients' global assessment. However, no significant differences were found in terms of functioning, pain level, emotional distress, and pain cognition when comparing patient education with usual care, no intervention, or waiting list.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set

Melanie B. Morillon, Alexander Norup, Jasvinder A. Singh, Nicola Dalbeth, William J. Taylor, Martin A. Kennedy, Birthe Mette Pedersen, Rebecca Grainger, Peter Tugwell, Fernando Perez-Ruiz, Cesar Diaz-Torne, N. Lawrence Edwards, Beverley Shea, Torkell J. Ellingsen, Robin Christensen, Lisa K. Stamp

Summary: This study aimed to assess the adherence of gout clinical trials to the core outcome domains endorsed by OMERACT in 2009 and evaluate the reporting before and after the endorsement. The results showed that only a small percentage of acute trials (8%) and no chronic trials reported all the core domains. Therefore, there is a need for continuous encouragement and further guidance on outcome measurement reporting among gout researchers.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

Review Medicine, General & Internal

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Mina Nicole Handel, Isabel Cardoso, Cecilie von Bulow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen

Summary: This study aimed to review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterize the effect of antiosteoporosis drug treatments on the risk of fractures according to baseline risk factors. The results showed that osteoporosis treatments had a protective effect on reducing fracture risk, and bone anabolic agents were more effective than bisphosphonates.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Medicine, General & Internal

Effect of single versus multiple prophylactic antibiotic doses on prosthetic joint infections following primary total hip arthroplasty in patients with osteoarthritis at public and private hospitals in Denmark: protocol for a nationwide cross-over, cluster randomised, non-inferiority trial [The Pro-Hip-Quality Trial]

Armita Armina Abedi, Claus Varnum, Alma Becic Pedersen, Kirill Gromov, Jesper Hallas, Pernille Iversen, Thomas Jakobsen, Espen Jimenez-Solem, Kristian Kidholm, Anne Kjerulf, Jeppe Lange, Anders Odgaard, Flemming S. Rosenvinge, Soren Solgaard, Kim Sperling, Marc Stegger, Robin Christensen, Soren Overgaard

Summary: Prosthetic joint infection (PJI) is a feared complication after total hip arthroplasty (THA) and is associated with high morbidity and mortality. Prophylactic antibiotics can reduce the risk of PJI, but there is no consensus on the dosages. This study aims to compare the effect of a single versus multiple doses of prophylactic antibiotics on PJI.

BMJ OPEN (2023)

Review Rheumatology

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials

Josefine B. H. Adelhelm, Robin Christensen, Gustavo G. M. Balbi, Anne Voss

Summary: This study aims to evaluate the effectiveness of DOACs compared with VKAs in the secondary prevention of thromboembolic events in patients with APS. According to the results, DOACs are associated with a significant increase in the risk of new thrombotic events, especially arterial thrombosis.

LUPUS SCIENCE & MEDICINE (2023)

Article Medicine, General & Internal

A framework for the definition and interpretation of the use of in interventional trials

Oriana Ciani, Anthony M. Manyara, Philippa Davies, Derek Stewart, Christopher J. Weir, Amber E. Young, Jane Blazeby, Nancy J. Butcher, Sylwia Bujkiewicz, An-Wen Chan, Dalia Dawoud, Martin Offringa, Mario Ouwens, Asbjorn Hrobjartssson, Alain Amstutz, Luca Bertolaccini, Vito Domenico Bruno, Declan Devane, Christina D. C. M. Faria, Peter B. Gilbert, Ray Harris, Marissa Lassere, Lucio Marinelli, Sarah Markham, John H. Powers, Yousef Rezaei, Laura Richert, Falk Schwendicke, Larisa G. Tereshchenko, Achilles Thoma, Alparslan Turan, Andrew Worrall, Robin Christensen, Gary S. Collins, Joseph S. Ross, Rod S. Taylor

Summary: Interventional trials that use surrogate endpoints to evaluate treatment effects are increasingly common. However, there is currently inconsistency and lack of clarity in the definition and interpretation of surrogate endpoints. Surrogate endpoints are used as substitutes for the treatment effects on ultimate outcomes of interest. While traditionally biomarkers have been the focus of surrogate endpoint consideration, intermediate outcomes that include measures of function or symptoms can also act as surrogate endpoints. However, there is a lack of consensus among stakeholders on accepting and interpreting intermediate outcomes as surrogate endpoints. Better understanding and reporting on the use of surrogate endpoints in interventional trials is urgently needed.

ECLINICALMEDICINE (2023)

Article Rheumatology

Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study

Andriko Palmowski, Zhivana Boyadzhieva, Sabrina M. Nielsen, Burkhard Muche, Sandra Hermann, Maarten Boers, Henning Bliddal, Robin Christensen, Edgar Wiebe, Frank Buttgereit

Summary: This study investigated whether the association between glucocorticoid (GC) use and reduced bone mineral density (BMD) in rheumatoid arthritis (RA) patients is modified by sex or age. The results showed no significant differences in the association between GC use and BMD reduction, regardless of sex or age.

ARTHRITIS RESEARCH & THERAPY (2023)

Article Rheumatology

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Dorthe B. Berthelsen, Lee S. Simon, John P. A. Ioannidis, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand, Sabrina M. Nielsen, Beverly J. Shea, Peter Tugwell, Susan J. Bartlett, Glen S. Hazlewood, Lyn March, Jasvinder A. Singh, Maria E. Suarez-Almazor, Maarten Boers, Randall M. Stevens, Daniel E. Furst, Thasia Woodworth, Amye Leong, Peter M. Brooks, Caroline Flurey, Robin Christensen

Summary: This study aims to develop an understanding of the safety/harm concept in clinical trials for patients with rheumatic and musculoskeletal diseases (RMDs). The study presents a detailed definition of safety/harms and concludes that enough qualitative data are available to begin a Delphi survey.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

Review Multidisciplinary Sciences

Interventions promoting recovery from depression for patients transitioning from outpatient mental health services to primary care: Protocol for a scoping review

Anne Sofie Aggestrup, Frederik Martiny, Maria Faurholt-Jepsen, Morten Hvenegaard, Robin Christensen, Annette Sofie Davidsen, Klaus Martiny

Summary: This article explores the recurrent nature of Major Depressive Disorder (MDD) and the residual symptoms of depression that may contribute to a high risk of relapse for patients transitioning from outpatient mental health services to primary care. The proposed scoping review aims to identify interventions that promote recovery from MDD and fill the knowledge gaps in this area.

PLOS ONE (2023)

No Data Available